High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23

Objective: Iron isomaltoside (Monofer(®)) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the safety and efficacy, including effect on intact fibroblast growth factor...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Scand J Gastroenterol
Glavni autori: Dahlerup, Jens Frederik, Jacobsen, Bent A., van der Woude, Janneke, Bark, Lars-Åke, Thomsen, Lars L., Lindgren, Stefan
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5152597/
https://ncbi.nlm.nih.gov/pubmed/27326766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00365521.2016.1196496
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items